0001563880-21-000003.txt : 20211021 0001563880-21-000003.hdr.sgml : 20211021 20211021162529 ACCESSION NUMBER: 0001563880-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211021 DATE AS OF CHANGE: 20211021 EFFECTIVENESS DATE: 20211021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trevi Therapeutics, Inc. CENTRAL INDEX KEY: 0001563880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450834299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-418073 FILM NUMBER: 211337275 BUSINESS ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-304-2499 MAIL ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 D 1 primary_doc.xml X0708 D LIVE 0001563880 Trevi Therapeutics, Inc. 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT CONNECTICUT 06510 203-304-2499 DELAWARE None None Corporation true Jennifer L. Good 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Executive Officer Director David Meeker 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Director James Cassella 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Director Edward Mathers 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Director Michael Heffernan 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Director Dominick Colangelo 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Director Anne VanLent 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Director Thomas Sciascia 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Executive Officer Lisa Delfini 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Executive Officer William Forbes 195 Church Street 14th Floor New Haven CT CONNECTICUT 06510 Executive Officer Biotechnology Decline to Disclose 06b false 2021-10-18 false true true true false 0 3000000 3000000 0 false 1 0 0 0 false Trevi Therapeutics, Inc. /s/ Jennifer L. Good Jennifer L. Good President and Chief Executive Officer 2021-10-21